Scholarlink

Background <p>Antimicrobial resistance (AMR) in <i>Escherichia coli</i>, particularly among animal-derived isolates, poses a major threat to public and veterinary health. With conventional antibiotics becoming increasingly ineffective against multidrug-resistant (MDR) strains, alternative solutions are urgently needed. Lytic bacteriophages, known for their host specificity and potent antibacterial activity, are promising therapeutic options. However, limited genomic data on phages from diverse ecological contexts hinder a comprehensive understanding of their diversity and functional potential.</p> Methods <p>This study aimed to isolate, characterize, and assess the therapeutic potential of lytic bacteriophages targeting MDR <i>E. coli</i> isolated from livestock. Phages were enriched from the sewage samples using an MDR <i>E. coli</i> host. Plaque morphology was assessed for lytic characteristics, and Transmission Electron Microscopy (TEM) was used for morphological identification. The thermal and pH stabilities were assessed under controlled incubation conditions. The host range was determined using 20 MDR <i>E. coli</i> strains from cattle, buffalo, and goats. One-step growth experiments were performed to determine the latent period and burst size of the phages. Whole-genome sequencing and annotation were performed to determine the genetic features, taxonomic classification, safety, and phylogenetic relationships.</p> Results <p>Three lytic <i>Escherichia</i> phage BASUE2, BASUE7, and BASUE10, were isolated, producing clear plaques indicative of strong lytic activity. All phages remained viable between 25 °C and 42°C and within pH 6–9, but were inactivated at 80°C and at highly acidic or alkaline conditions. BASUE7 exhibited the broadest host range, lysing 75% of MDR <i>E. coli</i> isolates, followed by BASUE2 (65%) and BASUE10 (55%), while none of the phages were active against <i>K. pneumoniae</i>, <i>S. aureus</i>, or <i>Salmonella</i> spp. Genome analysis revealed double-stranded DNA genomes of approximately 157 kb (BASUE2), 50 kb (BASUE7), and 48 kb (BASUE10), with G + C contents ranging from 44.62% to 45.47%. Taxonomically, BASUE2 was classified under <i>Ackermannviridae</i>, whereas BASUE7 and BASUE10 belonged to <i>Siphoviridae</i>, all within <i>Caudovirales</i>. All phages were predicted to be strictly lytic and lacked genes associated with lysogeny, antibiotic resistance, or virulence. Phylogenetic analysis revealed a distinct cluster of BASUE2, suggesting a divergent evolutionary origin from BASUE7 and BASUE10.</p> Conclusion <p>This study presents the isolation of genetically safe, environmentally stable, and broadly active lytic phages effective against MDR <i>E. coli</i> of animal origin. These findings highlight the potential of these phages for use in veterinary therapy. However, further in vivo validation and development of phage cocktails are necessary to advance their clinical applications.</p> Graphical Abstract <p>Graphical representation of isolation and characterization of <i>E. coli</i> bacteriophages from sewage samples.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Phenotypic and genomic characterization of three lytic bacteriophages against MDR Escherichia coli from livestock in India

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年2月7日

查看全文
  • Anjay,
  • Purushottam Kaushik,
  • Awadhesh Prajapati,
  • Rohit Kumar Jaiswal,
  • Bhoomika,
  • Seuli Saha Roy,
  • Ajeet Kumar,
  • Sudha Kumari,
  • Archana,
  • Baleshwari Dixit

摘要

Background

Antimicrobial resistance (AMR) in Escherichia coli, particularly among animal-derived isolates, poses a major threat to public and veterinary health. With conventional antibiotics becoming increasingly ineffective against multidrug-resistant (MDR) strains, alternative solutions are urgently needed. Lytic bacteriophages, known for their host specificity and potent antibacterial activity, are promising therapeutic options. However, limited genomic data on phages from diverse ecological contexts hinder a comprehensive understanding of their diversity and functional potential.

Methods

This study aimed to isolate, characterize, and assess the therapeutic potential of lytic bacteriophages targeting MDR E. coli isolated from livestock. Phages were enriched from the sewage samples using an MDR E. coli host. Plaque morphology was assessed for lytic characteristics, and Transmission Electron Microscopy (TEM) was used for morphological identification. The thermal and pH stabilities were assessed under controlled incubation conditions. The host range was determined using 20 MDR E. coli strains from cattle, buffalo, and goats. One-step growth experiments were performed to determine the latent period and burst size of the phages. Whole-genome sequencing and annotation were performed to determine the genetic features, taxonomic classification, safety, and phylogenetic relationships.

Results

Three lytic Escherichia phage BASUE2, BASUE7, and BASUE10, were isolated, producing clear plaques indicative of strong lytic activity. All phages remained viable between 25 °C and 42°C and within pH 6–9, but were inactivated at 80°C and at highly acidic or alkaline conditions. BASUE7 exhibited the broadest host range, lysing 75% of MDR E. coli isolates, followed by BASUE2 (65%) and BASUE10 (55%), while none of the phages were active against K. pneumoniae, S. aureus, or Salmonella spp. Genome analysis revealed double-stranded DNA genomes of approximately 157 kb (BASUE2), 50 kb (BASUE7), and 48 kb (BASUE10), with G + C contents ranging from 44.62% to 45.47%. Taxonomically, BASUE2 was classified under Ackermannviridae, whereas BASUE7 and BASUE10 belonged to Siphoviridae, all within Caudovirales. All phages were predicted to be strictly lytic and lacked genes associated with lysogeny, antibiotic resistance, or virulence. Phylogenetic analysis revealed a distinct cluster of BASUE2, suggesting a divergent evolutionary origin from BASUE7 and BASUE10.

Conclusion

This study presents the isolation of genetically safe, environmentally stable, and broadly active lytic phages effective against MDR E. coli of animal origin. These findings highlight the potential of these phages for use in veterinary therapy. However, further in vivo validation and development of phage cocktails are necessary to advance their clinical applications.

Graphical Abstract

Graphical representation of isolation and characterization of E. coli bacteriophages from sewage samples.